Home › Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
 

Keywords :   


Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

2013-02-21 19:16:21| Biotech - Topix.net

The iShares NASDAQ Biotechnology Index , the SPDR S&P Biotech ETF and the First Trust Amex Biotechnology Index ETF have all gained over 20 percent in the past year, outperforming the broader markets by a good margin.

Tags: high industry reach drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »